SERMRaloxifeneKi-67RateBRCAGeneStagingFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.CachexiaCo-survivorTamoxifenMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltGeneticPredispositionAdjuvantTherapyGeneticCounselingFibroadenomaBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55DoxorubicinPhysicalactivity mayreduce therisk of breastcancersAdenocarcinomaMetastasisAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerLapatinib1 in 8womenWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.ER-mTORInhibitorsMastectomyHormoneReplacementTherapyECOGScoreDefinitiveSurgeryAngiogenesisCMFChemotherapyCyclophosphamideImmunotherapyRelapseApoptosisACChemotherapyKappaEpsilonGenomicTestingBI-RADSWomen ages40+ shouldhave a clinicalbreast examat least yearlyEstrogenDown-StagingLymphoscintigraphyTumorGradeMultimodalityTherapyFlowCytometrySelf-examinationCalcificationsAxillarySamplingMRIProgestinER+LumpectomyEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearHormoneReceptorStatusIn-situCarcinomaHerceptinBiopsyGailModelOvarianSuppressionTriple +/-BreastCancerMethotrexateOligometastasesCystFamilyHistoryCDK4/6InhibitorsPalpationAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenCytostaticEGFRDimplingRadiotherapyFISHAlopeciaBreastTomosynthesisCapecitabineBevacizumabGeneMutationBOCAPARPInhibitorsAbsoluteRiskBreastCancerHER-2LumpPrecisionMedicineTyrosine-KinaseInhibitorAnastrozoleIntraductalPapillomaAdvocacyCheckpointInhibitorAromataseInhibitorsNeoadjuvantTherapyPalbociclibPathologicResponseAyurvedaBilateralProphylacticMastectomyPaclitaxelMastodyniaCytotoxicBrachytherapyGermlineMutationLCISLymphNodeStatusPI3KinaseInhibitors5-FluorouracilRADMorpheaAntiemeticGuaranteedRenewableInsuranceAntibodyTherapyPhyllodesTumorChemopreventionMegestrolAcetateDocetaxelEstradiolDoseDenseTherapyMultifocalTumorsPagetDiseaseCAMChemotherapySERMRaloxifeneKi-67RateBRCAGeneStagingFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.CachexiaCo-survivorTamoxifenMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltGeneticPredispositionAdjuvantTherapyGeneticCounselingFibroadenomaBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55DoxorubicinPhysicalactivity mayreduce therisk of breastcancersAdenocarcinomaMetastasisAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerLapatinib1 in 8womenWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.ER-mTORInhibitorsMastectomyHormoneReplacementTherapyECOGScoreDefinitiveSurgeryAngiogenesisCMFChemotherapyCyclophosphamideImmunotherapyRelapseApoptosisACChemotherapyKappaEpsilonGenomicTestingBI-RADSWomen ages40+ shouldhave a clinicalbreast examat least yearlyEstrogenDown-StagingLymphoscintigraphyTumorGradeMultimodalityTherapyFlowCytometrySelf-examinationCalcificationsAxillarySamplingMRIProgestinER+LumpectomyEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearHormoneReceptorStatusIn-situCarcinomaHerceptinBiopsyGailModelOvarianSuppressionTriple +/-BreastCancerMethotrexateOligometastasesCystFamilyHistoryCDK4/6InhibitorsPalpationAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenCytostaticEGFRDimplingRadiotherapyFISHAlopeciaBreastTomosynthesisCapecitabineBevacizumabGeneMutationBOCAPARPInhibitorsAbsoluteRiskBreastCancerHER-2LumpPrecisionMedicineTyrosine-KinaseInhibitorAnastrozoleIntraductalPapillomaAdvocacyCheckpointInhibitorAromataseInhibitorsNeoadjuvantTherapyPalbociclibPathologicResponseAyurvedaBilateralProphylacticMastectomyPaclitaxelMastodyniaCytotoxicBrachytherapyGermlineMutationLCISLymphNodeStatusPI3KinaseInhibitors5-FluorouracilRADMorpheaAntiemeticGuaranteedRenewableInsuranceAntibodyTherapyPhyllodesTumorChemopreventionMegestrolAcetateDocetaxelEstradiolDoseDenseTherapyMultifocalTumorsPagetDiseaseCAMChemotherapy

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
  1. SERM
  2. Raloxifene
  3. Ki-67 Rate
  4. BRCA Gene
  5. Staging
  6. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  7. Cachexia
  8. Co-survivor
  9. Tamoxifen
  10. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  11. Genetic Predisposition
  12. Adjuvant Therapy
  13. Genetic Counseling
  14. Fibroadenoma
  15. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  16. Doxorubicin
  17. Physical activity may reduce the risk of breast cancers
  18. Adenocarcinoma
  19. Metastasis
  20. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  21. Lapatinib
  22. 1 in 8 women
  23. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  24. ER-
  25. mTOR Inhibitors
  26. Mastectomy
  27. Hormone Replacement Therapy
  28. ECOG Score
  29. Definitive Surgery
  30. Angiogenesis
  31. CMF Chemotherapy
  32. Cyclophosphamide
  33. Immunotherapy
  34. Relapse
  35. Apoptosis
  36. AC Chemotherapy
  37. Kappa Epsilon
  38. Genomic Testing
  39. BI-RADS
  40. Women ages 40+ should have a clinical breast exam at least yearly
  41. Estrogen
  42. Down-Staging
  43. Lymphoscintigraphy
  44. Tumor Grade
  45. Multimodality Therapy
  46. Flow Cytometry
  47. Self-examination
  48. Calcifications
  49. Axillary Sampling
  50. MRI
  51. Progestin
  52. ER+
  53. Lumpectomy
  54. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  55. Hormone Receptor Status
  56. In-situ Carcinoma
  57. Herceptin
  58. Biopsy
  59. Gail Model
  60. Ovarian Suppression
  61. Triple +/- Breast Cancer
  62. Methotrexate
  63. Oligometastases
  64. Cyst
  65. Family History
  66. CDK4/6 Inhibitors
  67. Palpation
  68. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  69. Cytostatic
  70. EGFR
  71. Dimpling
  72. Radiotherapy
  73. FISH
  74. Alopecia
  75. Breast Tomosynthesis
  76. Capecitabine
  77. Bevacizumab
  78. Gene Mutation
  79. BOCA
  80. PARP Inhibitors
  81. Absolute Risk
  82. Breast Cancer
  83. HER-2
  84. Lump
  85. Precision Medicine
  86. Tyrosine-Kinase Inhibitor
  87. Anastrozole
  88. Intraductal Papilloma
  89. Advocacy
  90. Checkpoint Inhibitor
  91. Aromatase Inhibitors
  92. Neoadjuvant Therapy
  93. Palbociclib
  94. Pathologic Response
  95. Ayurveda
  96. Bilateral Prophylactic Mastectomy
  97. Paclitaxel
  98. Mastodynia
  99. Cytotoxic
  100. Brachytherapy
  101. Germline Mutation
  102. LCIS
  103. Lymph Node Status
  104. PI3 Kinase Inhibitors
  105. 5-Fluorouracil
  106. RAD
  107. Morphea
  108. Antiemetic
  109. Guaranteed Renewable Insurance
  110. Antibody Therapy
  111. Phyllodes Tumor
  112. Chemoprevention
  113. Megestrol Acetate
  114. Docetaxel
  115. Estradiol
  116. Dose Dense Therapy
  117. Multifocal Tumors
  118. Paget Disease
  119. CAM
  120. Chemotherapy